-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Cross Country Healthcare, Lowers Price Target to $16.5

Benzinga·05/13/2025 16:34:57
Listen to the news
UBS analyst A.J. Rice maintains Cross Country Healthcare (NASDAQ:CCRN) with a Neutral and lowers the price target from $18.61 to $16.5.